TERT and hepatocellular carcinoma: Nault et al. [56] identified frequent somatic mutations resulting in the activation of the TERT promoter in HCC (59%), cirrhotic preneoplastic macronodules (25%), and hepatocellular adenomas with malignant transformation in HCC (44%).